David van de Vijver

Datos Biográficos

ID8931420
NOMBREDavid van de Vijver
NOMBRESDavid
APELLIDOvan de Vijver
FIRMAVAN DE VIJVER D
AFILIACIONESViroscience Department, Erasmus Medical Centre, Rotterdam, Netherlands
ORCID0000-0001-5877-8526
VERIFICADOSí
TOTAL DE OBRAS2
TOTAL DE CITAS0
TOTAL COMO AUTOR2
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2022
AÑO MÁS RECIENTE DE PUBLICACIÓN2024
ÍNDICE H0

  • Intention and preference to use long-acting injectable PrEP among MSM in the Netherlands

    Open AccessHaoyi Wang, Hanne M L Zimmermann et al.ARTICLEAIDS Care2024

    Long-acting injectable pre-exposure prophylaxis (LAI-PrEP) is efficacious in preventing HIV among men-who-have-sex-with-men (MSM) and will be soon available in Europe. This study investigated the intention and preference to use LAI-PrEP among MSM in the Netherlands by employing a diffusion of innovation approach. This study had a cross-sectional design nested within a cohort study established in 2017 to understand oral PrEP use among MSM. 309 MSM…

  • Clinical outcomes among adolescents living with HIV in Kenya following initiation on antiretroviral treatment

    Open AccessJudith Kose, Appolinaire Tiam et al.ARTICLEPLOS Global Public Health2022

    In Kenya, HIV/AIDS remains a leading cause of morbidity and mortality among adolescents living with HIV (ALHIV). Our study evaluated associations between demographic and healthcare factors and HIV treatment outcomes among ALHIV in care in Kenya. This retrospective cohort study evaluated the clinical outcomes of newly diagnosed ALHIV enrolled in HIV care during January 2017-June 2018 at 32 healthcare facilities in Homabay and Kakamega Counties. De…